pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,970 catalysts · 4,970 phase readout · 2,347 8k filing · 287 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 18 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: device recall×type: phase readout×clear all
type
  • phase readout4,970
  • 8k filing2,347
  • earnings287
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07421323: Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated Infection

    Sponsor: Alexandria University. Phase: NA. Conditions: Neonatal Sepsis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06198023: Targeting Social Function in Anxiety and Eating Disorders

    Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Atypical Anorexia Nervosa, Purging (Eating Disorders), Other Specified Feeding or Eating Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder (GAD)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03747120: Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: HER2-positive Breast Cancer, Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06134882: OUD Smartphone Services

    Sponsor: Western Michigan University. Phase: NA. Conditions: Opioid-Related Disorders, Drug Abuse

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07216482: A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Hyperlipidemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07470450: Acute and Chronic Effects of Combined Training on BP in Hypertensives

    Sponsor: Federal University of Rio Grande do Sul. Phase: NA. Conditions: Dynamic Strength Exercise Session, Isometric Strength Exercise Session, Combined Exercise Session, Control Session (CON), Dynamic Strength Training, Combined Strength Training, Isometric Strength Training

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07417891: Ketogenic Diet to Reduce Osteoarthritis Pain in MCI

    Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Osteoarthritis (OA) of the Hip, Osteoarthritis (OA) of the Knee, Osteoarthritis (OA) of the Shoulder, Osteoarthritis, Mild Cognitive Impairment, MCI, Mild Cognitive Impairment (MCI), Dementia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06045975: Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: HCC - Hepatocellular Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07437157: The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register

    Sponsor: Chinese University of Hong Kong. Phase: . Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Type 2 Diabetes (T2DM)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05467657: Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke

    Sponsor: Neuron, Spain. Phase: NA. Conditions: Transcranial Magnetic Stimulation, Stroke, Motor Learning

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06212557: KIOS Mobile App Evaluation

    Sponsor: The University of Texas Health Science Center at San Antonio. Phase: NA. Conditions: Opioid Use Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01753557: Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

    Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Hepatitis C (CHC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06430957: OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

    Sponsor: Kırıkkale University. Phase: . Conditions: Obstructive Sleep Apnea Risk Management, Postoperative Complications, Dental Caries Under General Anesthesia, Obstructive Sleep Apnea of Adult

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07030101: A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

    Sponsor: EMS. Phase: PHASE3. Conditions: Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07491601: PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

    Sponsor: Nicolas Schlegel. Phase: NA. Conditions: Postoperative Hypoparathyroidism, Postsurgical Hypoparathyroidism, Hypoparathyroidism Post-surgical

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07702981: Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

    Sponsor: University Hospital, Ioannina. Phase: . Conditions: Membranous Nephropathy, Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07484152: Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor

    Sponsor: University of Sao Paulo General Hospital. Phase: PHASE1. Conditions: Essential Tremor (ET)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07539233: A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma.

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: EARLY_PHASE1. Conditions: Multiple Myeloma (MM)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06504147: A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

    Sponsor: Oncoinvent Solutions AS. Phase: PHASE2. Conditions: Peritoneal Carcinomatosis, Ovarian Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06699849: Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

    Sponsor: CSL Behring. Phase: PHASE2. Conditions: Sickle Cell Disease Vaso-occlusive Crisis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05679349: Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

    Sponsor: Ronald Myers. Phase: NA. Conditions: Lung Carcinoma, Tobacco-Related Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01659749: Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria

    Sponsor: Emory University. Phase: NA. Conditions: Pregnancy, Phenylketonuria

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05886049: A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation, Secondary Acute Myeloid Leukemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06362148: Circulating Tumor DNA in Peripheral T-cell Lymphomas

    Sponsor: University of Aarhus. Phase: . Conditions: Peripheral T-cell Lymphoma, NK/T-Cell Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06992258: A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

    Sponsor: Criterium, Inc.. Phase: PHASE2. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06885658: Effectiveness of Visual Storytelling Intervention on Antibiotic Adherence in UTI Patients

    Sponsor: Xi'an Jiaotong University. Phase: NA. Conditions: Uncomplicated Urinary Tract Infection, Patient With Uncomplicated UTI

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07262658: Cognitive Disparities in Parkinson's Disease

    Sponsor: Duke University. Phase: . Conditions: Parkinson Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06927648: CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

    Sponsor: AstraZeneca. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07126548: A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Prostate Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02372448: Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Lung Neoplasms

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04815239: Early Intervention for Youth at High Risk for Bipolar Disorder

    Sponsor: University of Pittsburgh. Phase: NA. Conditions: Bipolar Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00001539: A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Lyme Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06217939: Early Intravenous Hydrocortisone in Sepsis

    Sponsor: Siriraj Hospital. Phase: NA. Conditions: Sepsis Severe, Shock, Septic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06537557: Application of an Early In-Hospital Temperature Management Protocol for Heat Stroke Patients

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: NA. Conditions: Heat Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03505801: Confirm Rx Insertable Cardiac Monitor SMART Registry

    Sponsor: Abbott Medical Devices. Phase: . Conditions: Cardiac Arrhythmias, Symptoms and Signs, Atrial Fibrillation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03561701: A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

    Sponsor: Mycovia Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Recurrent Vulvovaginal Candidiasis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07622901: Fasting InTervention for Endometrial Cancer

    Sponsor: University of Miami. Phase: NA. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07386912: Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

    Sponsor: Research Center Borstel. Phase: . Conditions: Asthma, COPD, Bacterial Pneumonia, Viral Pneumonia, Tuberculosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07568639: Multi-Site Cortical Puncture for DOR

    Sponsor: First Affiliated Hospital of Guangxi Medical University. Phase: NA. Conditions: Diminished Ovarian Reserve (DOR)

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06734039: Impact of Anatomy-Based Cochlear Implant Programming on Early Performance

    Sponsor: Med-El Corporation. Phase: NA. Conditions: Hearing Loss, Unilateral, Cochlear Implants, Hearing Loss, Sensorineural, Single-Sided Deafness (SSD), Asymmetric Hearing Loss

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06052839: Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

    Sponsor: Dan Zandberg. Phase: PHASE2. Conditions: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07000357: A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Cardiovascular Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04230512: Assessment of a Hybrid Pump for Vacuum Suspension of Prosthetic Sockets for Persons With Lower Limb Loss to Characterize the Effects of Added Movement on Socket-reaction Torques

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Amputation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07659847: Cardiovascular Assessment 5 Years After MIS-C

    Sponsor: Medical University of Warsaw. Phase: . Conditions: Multisystem Inflammatory Syndrome in Children (MIS-C), SARS-CoV-2 Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07577349: EWSs and 28-Day Mortality in Geriatric ED Patients

    Sponsor: Haseki Training and Research Hospital. Phase: . Conditions: Mortality, Clinical Deterioration, Geriatric Patients, Frailty, Emergency Department Visits

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07481149: Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)

    Sponsor: University Health Network, Toronto. Phase: PHASE3. Conditions: Chemotherapy-induced Peripheral Neuropathy (CIPN)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

    Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Alopecia Areata

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05378347: Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

    Sponsor: Medtronic Cardiovascular. Phase: NA. Conditions: Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06112249: SAFE Workplace Intervention for People With IDD

    Sponsor: Temple University. Phase: NA. Conditions: Communicable Diseases, Prevention, Workplace Intervention

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07329049: The Effect of Inspiratory Muscle Training on Cognitive Functions, Cerebral Oxygenation, and Neurotrophic Factor Level in Patients With Obstructive Sleep Apnea Syndrome

    Sponsor: Istinye University. Phase: NA. Conditions: Obstructive Sleep Apnea Syndrome (OSAS)

    full page →ctgov ↗
    ← prev
    page 85 of 100
    next →